Ipca Laboratories zooms despite getting VAI classification for Madhya Pradesh facility
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Ipca Laboratories is currently trading at Rs. 997.50, up by 61.30 points or 6.55% from its previous closing of Rs. 936.20 on the BSE.
The scrip opened at Rs. 960.05 and has touched a high and low of Rs. 1008.90 and Rs. 960.05 respectively. So far 138165 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1008.90 on 23-Oct-2023 and a 52 week low of Rs. 670.00 on 22-May-2023.
Last one week high and low of the scrip stood at Rs. 1008.90 and Rs. 933.55 respectively. The current market cap of the company is Rs. 25328.56 crore.
The promoters holding in the company stood at 46.29%, while Institutions and Non-Institutions held 44.91% and 8.81% respectively.
Ipca Laboratories has received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its Ratlam, Madhya Pradesh manufacturing facility. USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023. This facility is considered to be in a minimally acceptable state of compliance with regard to current good manufacturing practice (CGMP).
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations.
